Furthermore, several short peptides have been designed, based on the sequence of eIF4E binding partners, to specifically destabilize the eIF4E-eIF4G complex in the cell, representing a valuable approach to target eIF4E-mediated translation in cancer models[86,87,121,122]. The gene discussed is EIF4G1; the disease is cancer.